story of the week
Rolapitant Effectively Reduces Chemotherapy-Induced Nausea and Vomiting
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of Rolapitant for Prevention of Chemotherapy-Induced Nausea and Vomiting After Administration of Moderately Emetogenic Chemotherapy or Anthracycline and Cyclophosphamide Regimens in Patients With Cancer: A Randomized, Active-Controlled, Double-Blind, Phase 3 Trial
Lancet Oncol 2015 Aug 10;[EPub Ahead of Print], LS Schwartzberg, MR Modiano, BL Rapoport, MR Chasen, C Gridelli, L Urban, A Poma, S Arora, RM Navari, ID SchnadigFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.